Vaginal clear cell adenocarcinoma in the United States

Gynecologic Oncology

Volumn 61, Issue 1, 1996, Pages 113-115

  Trimble, Edward L ^a   Rubinstein, Lawrence V ^a   Menck, Herman R ^b   Hankey, Benjamin F ^a   Kosary, Carol ^a   Giusti, Ruthann M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b AMERICAN COLLEGE OF SURGEONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CLEAR CELL CARCINOMA; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT CANCER; STATISTICAL ANALYSIS; UNITED STATES; VAGINA CANCER;

EID: 0029921928     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0107     Document Type: Article

References (13)

1. Herbst, A. L., Ulfelder, H., and Poskanzer, D. C. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women, N. Engl. J. Med. 284, 878 (1971).
2. Greenwald, P., Barlow, J. J., Nasca, P. C., and Burnett, W. S. Vaginal cancer after maternal treatment with synthetic estrogens, N. Engl. J. Med. 285, 390-392 (1971).
3. Herbst, A. L., Robboy, S. J., Scully, R. E., and Poskanzer, D. C. Clear-cell adenocarcinoma of the vaginal and cervix in girls: Analysis of 170 registry cases, Am. J. Obstet. Gynecol. 119, 713 (1974).
4. Herbst, A. L. Clear cell adenocarcinoma and the current status of DES-exposed females, Cancer 48, 484 (1981).
5. Herbst, A. L., and Anderson, D. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol, Semin. Surg. Oncol. 6, 343 (1990).
6. Melnick, S., Cole, P., Anderson, D., and Herbst, A. L. Rates and risks of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix, N. Engl. J. Med. 316, 514 (1987).
7. Noller, K. L., and Fish, C. R. Diethylstilbestrol usage: Its interesting past, important present, and questionable future, Med. Clin. North Am. 58, 739.
8. NIH Workshop: Long-term effects of exposure to diethylstilbestrol (DES), Department of Health and Human Services, Bethesda, MD (1992).
9. Herbst, A. L. Vaginal clear cell cancer: Incidence, survival, and screening, in NIH Workshop: Long-term effects of exposure to diethylstilbestrol (DES), Department of Health and Human Services, Bethesda, MD (1992).
10. Miller, B. A., Ries, L. A. G., Hankey, B. F., Kosary, C. L., Harras, A., Devesa, S. S., and Edwards, B. K. (Eds). SEER cancer statistics review 1973-1990, United States Department of Health and Human Services, Bethesda, MD (1993).
11. Menck, H. R., Garfinkel, L., and Dood, G. D. Preliminary report of the National Cancer Data Base, Ca. Cancer J. Clin. 41, 7 (1991).
12. Steele, G. D., Winchester, D. P., Menck, H. R., and Murphy, G. P. National Cancer Data Base annual review of patient care 1993, American Cancer Society, Atlanta, GA (1993).
13. Horwitz, R. I., Viscoli, C. M., Merino, M., Brennan, T. A., Flannery, J. T., and Robboy, S. J. Clear cell adenocarcinoma of the vagina and cervix: Incidence, undetected disease, and diethylstilbestrol, J. Clin. Epidemiol. 41, 593 (1988).